Women's hormone care
Menopause hormone therapy, personalized to your history
Medical review pending · Last updated
Hot flashes, night sweats, sleep disruption, and vaginal dryness are common in perimenopause and menopause. Hormone therapy is the most effective treatment for many of these symptoms, if a licensed provider determines it is appropriate.
Symptoms hormone therapy may help
- Hot flashes and night sweats (vasomotor symptoms)
- Vaginal dryness and painful sex (genitourinary syndrome of menopause)
- Prevention of bone loss in appropriate patients
Learn the early signs: perimenopause symptoms.
Options a provider may discuss
- FDA-approved estradiol (patch, gel, pill) with a progestogen if you have a uterus
- Low-dose vaginal estrogen for genitourinary symptoms
- Non-hormonal prescription options for hot flashes
Who should not use systemic hormone therapy
Generally not recommended with a history of breast or endometrial cancer, blood clots, stroke, heart attack, active liver disease, or unexplained vaginal bleeding. Your provider will review your personal and family history.
Related: bremelanotide (PT-141) for low desire in premenopausal women.
Frequently asked questions
Is hormone therapy safe?
For many healthy people under 60 or within 10 years of menopause, The Menopause Society concludes benefits generally outweigh risks for bothersome symptoms. Risks depend on age, health history, and type of therapy, so your provider will individualize the decision.
Do I need progesterone?
If you have a uterus and take systemic estrogen, a progestogen is generally needed to protect the uterine lining. Your provider will explain options.
What about "bioidentical" compounded hormones?
FDA-approved products include estradiol and progesterone that are chemically identical to the body's hormones. Compounded hormone mixtures are not FDA-approved and are generally not recommended over approved products by major medical societies.
Sources
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022 (PubMed)
- FDA: Labeling changes to clarify benefit/risk considerations for menopausal hormone therapies (Nov 2025)
- NIH (National Institute on Aging): What is menopause?
Sources are listed for reference and do not imply endorsement. Regulatory status can change; check the date above.
Be first to know when we launch
Care through independent licensed clinicians, starting in select states.